SAN FRANCISCO – Wearable health startup Byteflies is partnering with biopharmaceutical company UCB to monitor seizures experienced by people with epilepsy. As part of a consortium, which includes UCB, the University of Leuven in Belgium, the Leuven University Hospital and product developer PiliPili, Byteflies is providing its SensorDot customizable wearable to monitor seizures in a test group of patients. “In partnership with Byteflies, UCB is excited to be at the forefront of next generation wearables, collaborating to evaluate the benefits of measuring patient symptoms and experiences which, in the future, could support individually tailored care approaches” said Erik Janssen, vice president and head of innovative solutions, Neurology Patient Value Unit, at UCB, in a statement. Byteflies recently raised $600,000 in capital from a group of private investors and plans to launch a wearable health toolkit later this year.
You are here: / / Byteflies, UCB partner to monitor epileptic seizures